An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

By sjmartinez • June 20, 2024

Shah A, Tabibian J, Buness C, Holtmann GJ. An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08497-4. Epub ahead of print. PMID: 38896361.

Tags: Adaptive treatment strategy, Digestive Diseases, Olive View DoM, Oral vancomycin, Orphan disease, Primary sclerosing cholangitis, Publications, rare disease, Therapeutic decision-making

Targeting lipidated amino acid deficiency mitigates fibrosis via a PPARα/CCL2 axis in metabolic dysfunction-associated steatohepatitis models

Anand SK, Das S, Arias F, Richard KS, Rohilla S, Ghrayeb A, McKinney MP, Wang L, Tan L, Ding J, Kumar D, Pandey N, Lee[...]

Fibroblasts restrain gut inflammation by IGF1-dependent regulation of innate lymphocytes

Lin Q, Liu RE, Wang Q, Kang L, Chen B, Lu Y, Zhang Y, Gu Z, Zhou Y, Liu H, Xu X, Cao Z, Tang[...]

Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings

Liu J, Shin A. Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings. Lancet. 2026 Sep 24:S0140-6736(26)01815-5. doi: 10.1016/S0140-6736(26)01815-5. Epub ahead of[...]